title: Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: report of a case.
abstract: We report a 67-year-old male with pneumonia in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration of oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromycin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.
authors.affiliation: Department of Internal Medicine, Veterans General Hospital, Kaohsiung, Taiwan R.O.C.
authors.forename: J H
authors.initials: JH
authors.lastname: Wang
authors.forename: J H
authors.initials: JH
authors.lastname: Wang
authors.forename: Y C
authors.initials: YC
authors.lastname: Liu
authors.forename: Y S
authors.initials: YS
authors.lastname: Chen
authors.forename: M Y
authors.initials: MY
authors.lastname: Yen
authors.forename: S R
authors.initials: SR
authors.lastname: Wann
authors.forename: D L
authors.initials: DL
authors.lastname: Cheng
mesh_terms: D000368:Aged; D017963:Azithromycin / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae; D006801:Humans; D008297:Male; D018410:Pneumonia, Bacterial / Q000188:drug therapy*
chemical_list: D017963:Azithromycin